Usman Sabir, Hong‐mei Gu & Da‐Wei Zhang. (2023)
Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (
MMPs
) in liver fibrosis
. Phytotherapy Research 37:11, pages 4932-4962.
Crossref
Tong Wang & Zi-hui Xu. (2023) Natural Compounds with Aldose Reductase (AR) Inhibition: A Class of
Medicative Agents for Fatty Liver Disease. Combinatorial Chemistry & High Throughput Screening 26:11, pages 1929-1944.
Crossref
Wenjuan Xu, Longde Wang, Yuanyuan Niu, Lanfang Mao, Xiaojuan Du, Ping Zhang, Zhengju Li, Hongfang Li & Ning Li. (2022) A review of edible plant-derived natural compounds for the therapy of liver fibrosis. European Journal of Gastroenterology & Hepatology 35:2, pages 133-152.
Crossref
Lihua Li, Kunpeng Wang, Rongjun Jia, Jing xie, Liman Ma, Zhiqing Hao, Weiwei Zhang, Jinggang Mo & Fu Ren. (2022) Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation. Redox Biology 56, pages 102435.
Crossref
Xianjun Liu, Xinxin Gao, Hao Li, Zhandong Li, Xiaoe Wang, Li Zhang, Bo Wang, Xinxin Chen, Xianglong Meng & Jiaao Yu. (2021) Ellagic acid exerts anti-fibrotic effects on hypertrophic scar fibroblasts via inhibition of TGF-β1/Smad2/3 pathway. Applied Biological Chemistry 64:1.
Crossref
Ajit Kumar, Preeti Kaushik, Sandra Incerpi, Jens Z. Pedersen, Sanjay Goel, Ashok K. Prasad, Vishwajeet Rohil, Virinder S. Parmar, Luciano Saso & Christophe Len. (2021) Evaluation of the Free Radical Scavenging Activities of Ellagic Acid and Ellagic Acid Peracetate by EPR Spectrometry. Molecules 26:16, pages 4800.
Crossref
Venkatasubramanian Aishwarya, Solairaja Solaipriya & Venkatabalasubramanian Sivaramakrishnan. (2020) Role of ellagic acid for the prevention and treatment of liver diseases. Phytotherapy Research 35:6, pages 2925-2944.
Crossref
Liang Zhao, Arshad Mehmood, Dongdong Yuan, Muhammad Usman, Mian Anjum Murtaza, Sanabil Yaqoob & Chengtao Wang. (2021) Protective Mechanism of Edible Food Plants against Alcoholic Liver Disease with Special Mention to Polyphenolic Compounds. Nutrients 13:5, pages 1612.
Crossref
Ambreen Shoaib, Saad Saeed Alqahtani, Lubna Azmi, Tarique Anwer, Andleeb Khan, Saeed Al Shahrani, Ajaz Ahmad & Muneeb U. Rehman. 2020. Therapeutic Applications of Honey and its Phytochemicals. Therapeutic Applications of Honey and its Phytochemicals
85
112
.
Longxin Qiu, Chang Guo & Baoyu Hua. (2019) Aldose Reductase Inhibitors of Plant Origin in the Prevention and Treatment of Alcoholic Liver Disease: A Minireview. BioMed Research International 2019, pages 1-8.
Crossref
Manjeshwar Shrinath Baliga, Arnadi Ramachandrayya Shivashankara, Sunitha Venkatesh, Harshith P. Bhat, Princy Louis Palatty, Ganesh Bhandari & Suresh Rao. 2019. Dietary Interventions in Liver Disease. Dietary Interventions in Liver Disease
79
89
.
Nehal A. AfifiMarwa A. IbrahimMona K. Galal. (2018) Hepatoprotective influence of quercetin and ellagic acid on thioacetamide-induced hepatotoxicity in rats. Canadian Journal of Physiology and Pharmacology 96:6, pages 624-629.
Crossref
Adilson Costa, Michael Yi Bonner & Jack L. Arbiser. (2016) Use of Polyphenolic Compounds in Dermatologic Oncology. American Journal of Clinical Dermatology 17:4, pages 369-385.
Crossref
Robert Domitrović & Iva Potočnjak. (2015) A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives. Archives of Toxicology 90:1, pages 39-79.
Crossref
Wylly Ramsés García-Niño & Cecilia Zazueta. (2015) Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection. Pharmacological Research 97, pages 84-103.
Crossref
Arnadi Ramachandrayya Shivashankara, Sunitha Venkatesh, Harshith P. Bhat, Princy Louis Palatty & Manjeshwar Shrinath Baliga. 2015. Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults. Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults
163
170
.
Nathalie Janel & Christophe Noll. 2014. Polyphenols in Human Health and Disease. Polyphenols in Human Health and Disease
665
679
.
Marta Marín, Rosa María Giner, José-Luis Ríos & María Carmen Recio. (2013) Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis. Journal of Ethnopharmacology 150:3, pages 925-934.
Crossref
Ming-cheng Lin & Mei-chin Yin. (2013) Preventive Effects of Ellagic Acid Against Doxorubicin-Induced Cardio-Toxicity in Mice. Cardiovascular Toxicology 13:3, pages 185-193.
Crossref
Saba, Somaira Khan, Suhel Parvez, Bhushan Chaudhari, Firoz Ahmad, Sameya Anjum & Sheikh Raisuddin. (2013) Ellagic acid attenuates bleomycin and cyclophosphamide-induced pulmonary toxicity in Wistar rats. Food and Chemical Toxicology 58, pages 210-219.
Crossref
Pulok K. Mukherjee, Niladri Maity, Neelesh K. Nema & Birendra K. Sarkar. 2013.
91
113
.
A.R. Shivashankara, V. Sunitha, H.P. Bhat, P.L. Palatty & M.S. Baliga. 2013. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease
743
758
.
Shi-Biao Wu, Keyvan Dastmalchi, Chunlin Long & Edward J. Kennelly. (2012) Metabolite Profiling of Jaboticaba (Myrciaria cauliflora) and Other Dark-Colored Fruit Juices. Journal of Agricultural and Food Chemistry 60:30, pages 7513-7525.
Crossref
Keyvan Dastmalchi, Gema Flores, Shi-Biao Wu, Chunhui Ma, Abdoulaye J. Dabo, Kathleen Whalen, Kurt A. Reynertson, Robert F. Foronjy, Jeanine M. D´Armiento & Edward J. Kennelly. (2012) Edible Myrciaria vexator fruits: Bioactive phenolics for potential COPD therapy. Bioorganic & Medicinal Chemistry 20:14, pages 4549-4555.
Crossref
Chandrashekaran Girish & Suresh Chandra Pradhan. (2011) Indian herbal medicines in the treatment of liver diseases: problems and promises. Fundamental & Clinical Pharmacology 26:2, pages 180-189.
Crossref
Arnadi Ramachandrayya Shivashankara, Aysha Azmidah, Raghavendra Haniadka, Manoj Ponadka Rai, Rajesh Arora & Manjeshwar Shrinath Baliga. (2012) Dietary agents in the prevention of alcohol-induced hepatotoxicty: preclinical observations. Food Funct. 3:2, pages 101-109.
Crossref
Mei-Ying Kuo, Hsiu-Chung Ou, Wen-Jane Lee, Wei-Wen Kuo, Ling-Ling Hwang, Tuzz-Ying Song, Chih-Yang Huang, Tsan-Hung Chiu, Kun-Ling Tsai, Chiou-Sheng Tsai & Wayne Huey-Herng Sheu. (2011) Ellagic Acid Inhibits Oxidized Low-Density Lipoprotein (OxLDL)-Induced Metalloproteinase (MMP) Expression by Modulating the Protein Kinase C-α/Extracellular Signal-Regulated Kinase/Peroxisome Proliferator-Activated Receptor γ/Nuclear Factor-κB (PKC-α/ERK/PPAR-γ/NF-κB) Signaling Pathway in Endothelial Cells. Journal of Agricultural and Food Chemistry 59:9, pages 5100-5108.
Crossref